| Factor Information | |
|---|---|
| Data ID | 917 |
| Factor | The mean bias for daily steps (steps/d) |
| Description | The mean bias for daily steps was greater in boys (-3,320 steps/d; 95%LoA -7,643 – 1,003; 39% MAP) than girls. |
| Biomarker | NA |
| Classification | C3 (lifestycle factor - exercise habit) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | assess the validity of physical activity from a commercial activity tracker against a research-grade accelerometer under free living conditions in children with CHD. |
| Conclusion | Commercial activity trackers provide opportunities to remotely monitor physical activity in children with CHD. The mean bias for daily steps was greater in boys (-3,320 steps/d; 95%LoA -7,643 – 1,003; 39% MAP) than girls. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 28347581 |
| Year | 2017 |
| Title | Validity of Commercial Activity Trackers in Children With Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | participants | |
| Region | Columbia,Canada | |
| Method | We assessed the association between devices using intraclass correlation coefficients (ICCs) and Bland-Altman plots. Receiver operating curves were used to identify Fitbit step cut points. | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | children with congenital heart disease (boys)(Treatment) | children with congenital heart disease (girls)(Control) |
| Number | N/A (total 30) | N/A (total 30) |
| Age | 10-18 years | 10-18 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | – 3,320 steps/d; 95%LoA-7,643–1,003; 39% MAP (in boys) | –1,389 steps/d; 95%LoA -7,133 – 4,356; 18% MAP (in girls) |
